Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-370461
Filing Date
2021-12-30
Accepted
2021-12-30 14:33:18
Documents
57
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q d221995d10q.htm   iXBRL 10-Q 1116321
2 EX-31.1 d221995dex311.htm EX-31.1 10542
3 EX-31.2 d221995dex312.htm EX-31.2 10621
4 EX-32 d221995dex32.htm EX-32 5302
  Complete submission text file 0001193125-21-370461.txt   5341731

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20211130.xsd EX-101.SCH 30809
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20211130_cal.xml EX-101.CAL 32856
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20211130_def.xml EX-101.DEF 259674
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20211130_lab.xml EX-101.LAB 321467
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20211130_pre.xml EX-101.PRE 293720
51 EXTRACTED XBRL INSTANCE DOCUMENT d221995d10q_htm.xml XML 924854
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 211532325
SIC: 2835 In Vitro & In Vivo Diagnostic Substances